Similar articles for PMID: 20664965

Year	Number of Results
1895	1
1921	1
1944	1
1994	1
1996	3
1997	1
1998	1
2000	5
2001	4
2002	7
2003	4
2004	5
2005	5
2006	6
2007	14
2008	13
2009	6
2010	9
2011	13
2012	9
2013	18
2014	17
2015	12
2016	16
2017	14
2018	15
2019	19
2020	32
2021	24
2022	15
2023	8
2024	0

1

Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography in differential diagnosis of benign and malignant intraductal papillary-mucinous neoplasm of the pancreas.

Tomimaru Y, Takeda Y, Tatsumi M, Kim T, Kobayashi S, Marubashi S, Eguchi H, Tanemura M, Kitagawa T, Nagano H, Umeshita K, Wakasa K, Doki Y, Mori M. Tomimaru Y, et al. Oncol Rep. 2010 Sep;24(3):613-20. doi: 10.3892/or_00000899. Oncol Rep. 2010. PMID: 20664965

2

Additional value of FDG PET/CT to contrast-enhanced CT in the differentiation between benign and malignant intraductal papillary mucinous neoplasms of the pancreas with mural nodules.

Takanami K, Hiraide T, Tsuda M, Nakamura Y, Kaneta T, Takase K, Fukuda H, Takahashi S. Takanami K, et al. Ann Nucl Med. 2011 Aug;25(7):501-10. doi: 10.1007/s12149-011-0494-y. Epub 2011 May 3. Ann Nucl Med. 2011. PMID: 21537945

3

18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.

Sperti C, Bissoli S, Pasquali C, Frison L, Liessi G, Chierichetti F, Pedrazzoli S. Sperti C, et al. Ann Surg. 2007 Dec;246(6):932-7; discussion 937-9. doi: 10.1097/SLA.0b013e31815c2a29. Ann Surg. 2007. PMID: 18043094

4

Usefulness of positron emission tomography (PET)/contrast-enhanced computed tomography (CE-CT) in discriminating between malignant and benign intraductal papillary mucinous neoplasms (IPMNs).

Ohta K, Tanada M, Sugawara Y, Teramoto N, Iguchi H. Ohta K, et al. Pancreatology. 2017 Nov-Dec;17(6):911-919. doi: 10.1016/j.pan.2017.09.010. Epub 2017 Oct 3. Pancreatology. 2017. PMID: 29033011

5

Use of F-18 fluorodeoxyglucose positron emission tomography with dual-phase imaging to identify intraductal papillary mucinous neoplasm.

Saito M, Ishihara T, Tada M, Tsuyuguchi T, Mikata R, Sakai Y, Tawada K, Sugiyama H, Kurosawa J, Otsuka M, Uchida Y, Uchiyama K, Miyazaki M, Yokosuka O. Saito M, et al. Clin Gastroenterol Hepatol. 2013 Feb;11(2):181-6. doi: 10.1016/j.cgh.2012.10.037. Epub 2012 Nov 6. Clin Gastroenterol Hepatol. 2013. PMID: 23142206

6

Comparison of International Consensus Guidelines versus 18-FDG PET in detecting malignancy of intraductal papillary mucinous neoplasms of the pancreas.

Pedrazzoli S, Sperti C, Pasquali C, Bissoli S, Chierichetti F. Pedrazzoli S, et al. Ann Surg. 2011 Dec;254(6):971-6. doi: 10.1097/SLA.0b013e3182383137. Ann Surg. 2011. PMID: 22076067

7

Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.

Ridtitid W, DeWitt JM, Schmidt CM, Roch A, Stuart JS, Sherman S, Al-Haddad MA. Ridtitid W, et al. Gastrointest Endosc. 2016 Sep;84(3):436-45. doi: 10.1016/j.gie.2016.02.008. Epub 2016 Feb 18. Gastrointest Endosc. 2016. PMID: 26905937 Free article.

8

The value of ¹⁸F-FDG positron emission tomography to differentiate benign from malignant intraductal papillary mucinous neoplasms: A prospective multicenter study.

Regenet N, Sauvanet A, Muscari F, Meunier B, Mariette C, Adham M, Moutardier V, Delpero JR, Regimbeau JM, Pessaux P, Paye F, Sa Cunha A, Ansquer C. Regenet N, et al. J Visc Surg. 2020 Oct;157(5):387-394. doi: 10.1016/j.jviscsurg.2020.01.006. Epub 2020 Jan 28. J Visc Surg. 2020. PMID: 32005594 Clinical Trial.

9

The utility of F-18 FDG PET/CT in the evaluation of pancreatic intraductal papillary mucinous neoplasm.

Hong HS, Yun M, Cho A, Choi JY, Kim MJ, Kim KW, Choi YJ, Lee JD. Hong HS, et al. Clin Nucl Med. 2010 Oct;35(10):776-9. doi: 10.1097/RLU.0b013e3181e4da32. Clin Nucl Med. 2010. PMID: 20838285

10

Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.

Santhosh S, Mittal BR, Bhasin D, Srinivasan R, Rana S, Das A, Nada R, Bhattacharya A, Gupta R, Kapoor R. Santhosh S, et al. J Gastroenterol Hepatol. 2013 Feb;28(2):255-61. doi: 10.1111/jgh.12068. J Gastroenterol Hepatol. 2013. PMID: 23278193

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

267 results

Results by year